Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Atea Pharmaceuticals, Inc. - common stock (NQ:AVIR)

3.589 +0.049 (+1.38%)
Streaming Delayed Price Updated: 12:20 PM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Atea Pharmaceuticals, Inc. - common stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Why Atea Pharmaceuticals Stock Is Sinking Today ↗
Roche calls it quits on the duo's attempt to develop an oral COVID-19 therapy. 
Via The Motley Fool
News headline image
Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill ↗
Roche Holdings AG (OTC: RHHBY) has ended a partnership with Atea Pharmaceuticals Inc (NASDAQ: AVIR) to jointly develop a COVID-19 antiviral pill, a month... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Atea Announces Termination of Strategic Collaboration With Roche Atea... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
News headline image
Earnings Scheduled For November 11, 2021 ↗
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... 
Via Benzinga
News headline image
Expert Ratings For Atea Pharmaceuticals ↗
Over the past 3 months, 5 analysts have published their opinion on Atea Pharmaceuticals (NASDAQ: 
Via Benzinga
News headline image
25 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10... 
Via Benzinga
News headline image
Atea Pharma Stock Collapses As Roche Pulls The Plug On Pfizer-Rivaling Covid Pill ↗
Roche and Atea's partnership will end in February. 
Via Investor's Business Daily
News headline image
Atea Pharmaceuticals Inc (AVIR) Q3 2021 Earnings Call Transcript ↗
AVIR earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals? ↗
Photo by Danilo Alvesd on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
News headline image
Is There Any Hope for Atea Pharmaceuticals Stock? ↗
If its coronavirus pill project can't be salvaged, it'll be trouble for investors. 
Via The Motley Fool
News headline image
3 Beaten-Down Biotech Stocks -- Can They Recover? ↗
Each for reasons of their own, Atea Pharmaceuticals, Omeros, and Novavax have had a very tough time this year. 
Via The Motley Fool
News headline image
How Atea's Clinical Flop Shakes Up the COVID-19 Pill Market ↗
Merck and Pfizer could benefit from Atea's setback. 
Via The Motley Fool
News headline image
Pfizer Conceding Race in Hospitalized Covid Because of Todos Medical's Triple MOA Antiviral ↗
Photo by Christina Victoria Craft on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a... 
Via Benzinga
News headline image
3 Top COVID Stocks -- Are They Tricks or Treats? ↗
Ghosts, goblins, ghouls? No, it's three vaccine stocks. 
Via The Motley Fool
News headline image
Was Atea Pharmaceutical's Flop Predictable? ↗
Were warning signs there for investors all along? 
Via The Motley Fool
News headline image
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More ↗
Last week, the five biggest stock market losers declined between about 75% and 37%. Below is a look at each stock and what they may have in the cards going forward. Galera... 
Via Benzinga
News headline image
Why Atea Pharmaceuticals Stock Got Crushed This Week ↗
A mid-stage trial miss caused investors to hit the exits this week. 
Via The Motley Fool
News headline image
10 Biggest Price Target Changes For Wednesday ↗
Mizuho cut QUALCOMM Incorporated (NASDAQ: QCOM) price target from $180 to $165. QUALCOMM shares fell 0.3% to $132.13 in pre-market trading. Deutsche Bank raised the price... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021 ↗
Upgrades For Iridium Communications Inc (NASDAQ:IRD... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher ↗
Toward the end of trading Tuesday, the Dow traded up 0.33% to 35,374.03 while the NASDAQ rose 0.54% to 15,103.67. The S&P also rose, gaining 0.55% to 4,511.35. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
52 Biggest Movers From Yesterday ↗
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares climbed 42.6% to close at $9.51 on Tuesday. Xiaobai Maimai said Xiaobao An resigned as CEO. Kaival Brands Innovations Group... 
Via Benzinga
News headline image
Why Ulta and Atea Rained on the Nasdaq's Parade Tuesday ↗
Even with downward pressure from these two stocks, the Nasdaq Composite moved higher again. 
Via The Motley Fool
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 18.27% to $5.76 during Tuesday's regular session. Redhill Biopharma's stock is trading at a volume of 2.... 
Via Benzinga
News headline image
Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge ↗
Midway through trading Tuesday, the Dow traded up 0.47% to 35,423.05 while the NASDAQ rose 0.59% to 15,110.79. The S&P also rose, gaining 0.61% to 4,513.69. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
Why Atea Pharmaceuticals Is Imploding Today ↗
The company's oral COVID-19 treatment looks like a dud in the mild-to-moderate COVID-19 setting. 
Via The Motley Fool
News headline image
AVIR Stock: The Oral Covid-19 Therapy News That Has Atea Pharmaceuticals Plunging Today ↗
Atea Pharmaceuticals (AVIR) stock is on the move Tuesday after providing an update from its Phase 2 Moonsong clinical trial update. 
Via InvestorPlace
News headline image
Atea Pharma Stock Crashes After Merck-Rivaling Covid Pill Lags In Midstage Test ↗
Atea Pharmaceuticals said its Covid pill didn't lower viral loads in all patients. 
Via Investor's Business Daily
News headline image
Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance ↗
Following the market opening Tuesday, the Dow traded up 0.29% to 35,361.89 while the NASDAQ rose 0.31% to 15,068.75. The S&P also rose, gaining 0.39% to 4,503.81. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market session. The company's market cap stands at $... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.